 | • レポートコード：GIR-107A12385 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、炎症性腸疾患治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。炎症性腸疾患治療の種類別市場規模（潰瘍性大腸炎、クローン病、その他）、用途別市場規模（病院、医学研究機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・炎症性腸疾患治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Johnson & Johnson、AbbVie、Takeda Pharmaceutical Company、Abbott、Celgene Corporation、Innovate Biopharma、Cosmo Pharmaceuticals、Gilead Sciences、Pfizer ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：潰瘍性大腸炎、クローン病、その他 ・用途別分析2016年-2026年：病院、医学研究機関、その他 ・炎症性腸疾患治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・炎症性腸疾患治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・炎症性腸疾患治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・炎症性腸疾患治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・炎症性腸疾患治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Inflammatory Bowel Disease Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Inflammatory Bowel Disease Therapy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Inflammatory Bowel Disease Therapy market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Inflammatory Bowel Disease Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Ulcerative Colitis
Crohns Disease
Others
Market segment by Application, can be divided into
Hospital
Medical Research Organization
Other
Market segment by players, this report covers
Johnson & Johnson
AbbVie
Takeda Pharmaceutical Company
Abbott
Celgene Corporation
Innovate Biopharma
Cosmo Pharmaceuticals
Gilead Sciences
Pfizer
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Inflammatory Bowel Disease Therapy
1.2 Classification of Inflammatory Bowel Disease Therapy by Type
1.2.1 Overview: Global Inflammatory Bowel Disease Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Inflammatory Bowel Disease Therapy Revenue Market Share by Type in 2020
1.2.3 Ulcerative Colitis
1.2.4 Crohns Disease
1.2.5 Others
1.3 Global Inflammatory Bowel Disease Therapy Market by Application
1.3.1 Overview: Global Inflammatory Bowel Disease Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Medical Research Organization
1.3.4 Other
1.4 Global Inflammatory Bowel Disease Therapy Market Size & Forecast
1.5 Global Inflammatory Bowel Disease Therapy Market Size and Forecast by Region
1.5.1 Global Inflammatory Bowel Disease Therapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Inflammatory Bowel Disease Therapy Market Size by Region, (2016-2021)
1.5.3 North America Inflammatory Bowel Disease Therapy Market Size and Prospect (2016-2026)
1.5.4 Europe Inflammatory Bowel Disease Therapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size and Prospect (2016-2026)
1.5.6 South America Inflammatory Bowel Disease Therapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Inflammatory Bowel Disease Therapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Inflammatory Bowel Disease Therapy Market Drivers
1.6.2 Inflammatory Bowel Disease Therapy Market Restraints
1.6.3 Inflammatory Bowel Disease Therapy Trends Analysis
2 Company Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Inflammatory Bowel Disease Therapy Product and Solutions
2.1.4 Johnson & Johnson Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Johnson & Johnson Recent Developments and Future Plans
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie Inflammatory Bowel Disease Therapy Product and Solutions
2.2.4 AbbVie Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 AbbVie Recent Developments and Future Plans
2.3 Takeda Pharmaceutical Company
2.3.1 Takeda Pharmaceutical Company Details
2.3.2 Takeda Pharmaceutical Company Major Business
2.3.3 Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Product and Solutions
2.3.4 Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Takeda Pharmaceutical Company Recent Developments and Future Plans
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Inflammatory Bowel Disease Therapy Product and Solutions
2.4.4 Abbott Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Abbott Recent Developments and Future Plans
2.5 Celgene Corporation
2.5.1 Celgene Corporation Details
2.5.2 Celgene Corporation Major Business
2.5.3 Celgene Corporation Inflammatory Bowel Disease Therapy Product and Solutions
2.5.4 Celgene Corporation Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Celgene Corporation Recent Developments and Future Plans
2.6 Innovate Biopharma
2.6.1 Innovate Biopharma Details
2.6.2 Innovate Biopharma Major Business
2.6.3 Innovate Biopharma Inflammatory Bowel Disease Therapy Product and Solutions
2.6.4 Innovate Biopharma Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Innovate Biopharma Recent Developments and Future Plans
2.7 Cosmo Pharmaceuticals
2.7.1 Cosmo Pharmaceuticals Details
2.7.2 Cosmo Pharmaceuticals Major Business
2.7.3 Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Product and Solutions
2.7.4 Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Cosmo Pharmaceuticals Recent Developments and Future Plans
2.8 Gilead Sciences
2.8.1 Gilead Sciences Details
2.8.2 Gilead Sciences Major Business
2.8.3 Gilead Sciences Inflammatory Bowel Disease Therapy Product and Solutions
2.8.4 Gilead Sciences Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Gilead Sciences Recent Developments and Future Plans
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Inflammatory Bowel Disease Therapy Product and Solutions
2.9.4 Pfizer Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Pfizer Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Inflammatory Bowel Disease Therapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Inflammatory Bowel Disease Therapy Players Market Share
3.2.2 Top 10 Inflammatory Bowel Disease Therapy Players Market Share
3.2.3 Market Competition Trend
3.3 Inflammatory Bowel Disease Therapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Inflammatory Bowel Disease Therapy Revenue and Market Share by Type (2016-2021)
4.2 Global Inflammatory Bowel Disease Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Inflammatory Bowel Disease Therapy Revenue Market Share by Application (2016-2021)
5.2 Inflammatory Bowel Disease Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Inflammatory Bowel Disease Therapy Revenue by Type (2016-2026)
6.2 North America Inflammatory Bowel Disease Therapy Revenue by Application (2016-2026)
6.3 North America Inflammatory Bowel Disease Therapy Market Size by Country
6.3.1 North America Inflammatory Bowel Disease Therapy Revenue by Country (2016-2026)
6.3.2 United States Inflammatory Bowel Disease Therapy Market Size and Forecast (2016-2026)
6.3.3 Canada Inflammatory Bowel Disease Therapy Market Size and Forecast (2016-2026)
6.3.4 Mexico Inflammatory Bowel Disease Therapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Inflammatory Bowel Disease Therapy Revenue by Type (2016-2026)
7.2 Europe Inflammatory Bowel Disease Therapy Revenue by Application (2016-2026)
7.3 Europe Inflammatory Bowel Disease Therapy Market Size by Country
7.3.1 Europe Inflammatory Bowel Disease Therapy Revenue by Country (2016-2026)
7.3.2 Germany Inflammatory Bowel Disease Therapy Market Size and Forecast (2016-2026)
7.3.3 France Inflammatory Bowel Disease Therapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Inflammatory Bowel Disease Therapy Market Size and Forecast (2016-2026)
7.3.5 Russia Inflammatory Bowel Disease Therapy Market Size and Forecast (2016-2026)
7.3.6 Italy Inflammatory Bowel Disease Therapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Inflammatory Bowel Disease Therapy Revenue by Type (2016-2026)
8.2 Asia-Pacific Inflammatory Bowel Disease Therapy Revenue by Application (2016-2026)
8.3 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Region
8.3.1 Asia-Pacific Inflammatory Bowel Disease Therapy Revenue by Region (2016-2026)
8.3.2 China Inflammatory Bowel Disease Therapy Market Size and Forecast (2016-2026)
8.3.3 Japan Inflammatory Bowel Disease Therapy Market Size and Forecast (2016-2026)
8.3.4 South Korea Inflammatory Bowel Disease Therapy Market Size and Forecast (2016-2026)
8.3.5 India Inflammatory Bowel Disease Therapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Inflammatory Bowel Disease Therapy Market Size and Forecast (2016-2026)
8.3.7 Australia Inflammatory Bowel Disease Therapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Inflammatory Bowel Disease Therapy Revenue by Type (2016-2026)
9.2 South America Inflammatory Bowel Disease Therapy Revenue by Application (2016-2026)
9.3 South America Inflammatory Bowel Disease Therapy Market Size by Country
9.3.1 South America Inflammatory Bowel Disease Therapy Revenue by Country (2016-2026)
9.3.2 Brazil Inflammatory Bowel Disease Therapy Market Size and Forecast (2016-2026)
9.3.3 Argentina Inflammatory Bowel Disease Therapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Inflammatory Bowel Disease Therapy Revenue by Type (2016-2026)
10.2 Middle East & Africa Inflammatory Bowel Disease Therapy Revenue by Application (2016-2026)
10.3 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Country
10.3.1 Middle East & Africa Inflammatory Bowel Disease Therapy Revenue by Country (2016-2026)
10.3.2 Turkey Inflammatory Bowel Disease Therapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Inflammatory Bowel Disease Therapy Market Size and Forecast (2016-2026)
10.3.4 UAE Inflammatory Bowel Disease Therapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Inflammatory Bowel Disease Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Inflammatory Bowel Disease Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Inflammatory Bowel Disease Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Inflammatory Bowel Disease Therapy Revenue (USD Million) by Region (2016-2021)
Table 5. Global Inflammatory Bowel Disease Therapy Revenue Market Share by Region (2021-2026)
Table 6. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 7. Johnson & Johnson Major Business
Table 8. Johnson & Johnson Inflammatory Bowel Disease Therapy Product and Solutions
Table 9. Johnson & Johnson Inflammatory Bowel Disease Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. AbbVie Corporate Information, Head Office, and Major Competitors
Table 11. AbbVie Major Business
Table 12. AbbVie Inflammatory Bowel Disease Therapy Product and Solutions
Table 13. AbbVie Inflammatory Bowel Disease Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Takeda Pharmaceutical Company Corporate Information, Head Office, and Major Competitors
Table 15. Takeda Pharmaceutical Company Major Business
Table 16. Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Product and Solutions
Table 17. Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Abbott Corporate Information, Head Office, and Major Competitors
Table 19. Abbott Major Business
Table 20. Abbott Inflammatory Bowel Disease Therapy Product and Solutions
Table 21. Abbott Inflammatory Bowel Disease Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Celgene Corporation Corporate Information, Head Office, and Major Competitors
Table 23. Celgene Corporation Major Business
Table 24. Celgene Corporation Inflammatory Bowel Disease Therapy Product and Solutions
Table 25. Celgene Corporation Inflammatory Bowel Disease Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Innovate Biopharma Corporate Information, Head Office, and Major Competitors
Table 27. Innovate Biopharma Major Business
Table 28. Innovate Biopharma Inflammatory Bowel Disease Therapy Product and Solutions
Table 29. Innovate Biopharma Inflammatory Bowel Disease Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Cosmo Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 31. Cosmo Pharmaceuticals Major Business
Table 32. Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Product and Solutions
Table 33. Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 35. Gilead Sciences Major Business
Table 36. Gilead Sciences Inflammatory Bowel Disease Therapy Product and Solutions
Table 37. Gilead Sciences Inflammatory Bowel Disease Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Pfizer Corporate Information, Head Office, and Major Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Inflammatory Bowel Disease Therapy Product and Solutions
Table 41. Pfizer Inflammatory Bowel Disease Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Inflammatory Bowel Disease Therapy Revenue (USD Million) by Players (2019-2021)
Table 43. Global Inflammatory Bowel Disease Therapy Revenue Share by Players (2019-2021)
Table 44. Breakdown of Inflammatory Bowel Disease Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Inflammatory Bowel Disease Therapy Players Head Office, Products and Services Provided
Table 46. Inflammatory Bowel Disease Therapy Mergers & Acquisitions in the Past Five Years
Table 47. Inflammatory Bowel Disease Therapy New Entrants and Expansion Plans
Table 48. Global Inflammatory Bowel Disease Therapy Revenue (USD Million) by Type (2016-2021)
Table 49. Global Inflammatory Bowel Disease Therapy Revenue Share by Type (2016-2021)
Table 50. Global Inflammatory Bowel Disease Therapy Revenue Forecast by Type (2021-2026)
Table 51. Global Inflammatory Bowel Disease Therapy Revenue by Application (2016-2021)
Table 52. Global Inflammatory Bowel Disease Therapy Revenue Forecast by Application (2021-2026)
Table 53. North America Inflammatory Bowel Disease Therapy Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Inflammatory Bowel Disease Therapy Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Inflammatory Bowel Disease Therapy Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Inflammatory Bowel Disease Therapy Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Inflammatory Bowel Disease Therapy Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Inflammatory Bowel Disease Therapy Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Inflammatory Bowel Disease Therapy Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Inflammatory Bowel Disease Therapy Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Inflammatory Bowel Disease Therapy Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Inflammatory Bowel Disease Therapy Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Inflammatory Bowel Disease Therapy Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Inflammatory Bowel Disease Therapy Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Inflammatory Bowel Disease Therapy Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Inflammatory Bowel Disease Therapy Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Inflammatory Bowel Disease Therapy Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Inflammatory Bowel Disease Therapy Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Inflammatory Bowel Disease Therapy Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Inflammatory Bowel Disease Therapy Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Inflammatory Bowel Disease Therapy Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Inflammatory Bowel Disease Therapy Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Inflammatory Bowel Disease Therapy Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Inflammatory Bowel Disease Therapy Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Inflammatory Bowel Disease Therapy Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Inflammatory Bowel Disease Therapy Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Inflammatory Bowel Disease Therapy Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Inflammatory Bowel Disease Therapy Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Inflammatory Bowel Disease Therapy Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Inflammatory Bowel Disease Therapy Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Inflammatory Bowel Disease Therapy Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Inflammatory Bowel Disease Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Inflammatory Bowel Disease Therapy Picture
Figure 2. Global Inflammatory Bowel Disease Therapy Revenue Market Share by Type in 2020
Figure 3. Ulcerative Colitis
Figure 4. Crohns Disease
Figure 5. Others
Figure 6. Inflammatory Bowel Disease Therapy Revenue Market Share by Application in 2020
Figure 7. Hospital Picture
Figure 8. Medical Research Organization Picture
Figure 9. Other Picture
Figure 10. Global Inflammatory Bowel Disease Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Inflammatory Bowel Disease Therapy Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Inflammatory Bowel Disease Therapy Revenue Market Share by Region (2016-2026)
Figure 13. Global Inflammatory Bowel Disease Therapy Revenue Market Share by Region in 2020
Figure 14. North America Inflammatory Bowel Disease Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Inflammatory Bowel Disease Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Inflammatory Bowel Disease Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Inflammatory Bowel Disease Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Inflammatory Bowel Disease Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Inflammatory Bowel Disease Therapy Market Drivers
Figure 20. Inflammatory Bowel Disease Therapy Market Restraints
Figure 21. Inflammatory Bowel Disease Therapy Market Trends
Figure 22. Johnson & Johnson Recent Developments and Future Plans
Figure 23. AbbVie Recent Developments and Future Plans
Figure 24. Takeda Pharmaceutical Company Recent Developments and Future Plans
Figure 25. Abbott Recent Developments and Future Plans
Figure 26. Celgene Corporation Recent Developments and Future Plans
Figure 27. Innovate Biopharma Recent Developments and Future Plans
Figure 28. Cosmo Pharmaceuticals Recent Developments and Future Plans
Figure 29. Gilead Sciences Recent Developments and Future Plans
Figure 30. Pfizer Recent Developments and Future Plans
Figure 31. Global Inflammatory Bowel Disease Therapy Revenue Share by Players in 2020
Figure 32. Inflammatory Bowel Disease Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Inflammatory Bowel Disease Therapy Revenue Market Share in 2020
Figure 34. Global Top 10 Players Inflammatory Bowel Disease Therapy Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Inflammatory Bowel Disease Therapy Revenue Share by Type in 2020
Figure 37. Global Inflammatory Bowel Disease Therapy Market Share Forecast by Type (2021-2026)
Figure 38. Global Inflammatory Bowel Disease Therapy Revenue Share by Application in 2020
Figure 39. Global Inflammatory Bowel Disease Therapy Market Share Forecast by Application (2021-2026)
Figure 40. North America Inflammatory Bowel Disease Therapy Sales Market Share by Type (2016-2026)
Figure 41. North America Inflammatory Bowel Disease Therapy Sales Market Share by Application (2016-2026)
Figure 42. North America Inflammatory Bowel Disease Therapy Revenue Market Share by Country (2016-2026)
Figure 43. United States Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Inflammatory Bowel Disease Therapy Sales Market Share by Type (2016-2026)
Figure 47. Europe Inflammatory Bowel Disease Therapy Sales Market Share by Application (2016-2026)
Figure 48. Europe Inflammatory Bowel Disease Therapy Revenue Market Share by Country (2016-2026)
Figure 49. Germany Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Inflammatory Bowel Disease Therapy Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Inflammatory Bowel Disease Therapy Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Inflammatory Bowel Disease Therapy Revenue Market Share by Region (2016-2026)
Figure 57. China Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Inflammatory Bowel Disease Therapy Sales Market Share by Type (2016-2026)
Figure 64. South America Inflammatory Bowel Disease Therapy Sales Market Share by Application (2016-2026)
Figure 65. South America Inflammatory Bowel Disease Therapy Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Inflammatory Bowel Disease Therapy Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Inflammatory Bowel Disease Therapy Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Inflammatory Bowel Disease Therapy Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界のIBD（潰瘍性大腸炎＆クローン病）治療市場 2021：企業別、地域別、種類・用途別 The IBD (Ulcerative Colitis and Crohn's Disease) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value ch…- 世界の消退骨病治療市場 2021：企業別、地域別、種類・用途別 The Vanishing Bone Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界のレフサム病治療市場 2021：企業別、地域別、種類・用途別 The Refsum Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の炎症性皮膚病治療薬市場 2021：企業別、地域別、種類・用途別 The Inflammatory Skin Diseases Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界の炎症性皮膚病治療市場 2021：企業別、地域別、種類・用途別 The Inflammatory Skin Diseases Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …